Saba Capital Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Saba Capital Management’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-94,264	Closed	-$193K	–	355
2025 Q2	$193K	Hold	94,264	–	–	﹤0.01%	216
2025 Q1	$107K	Hold	94,264	–	–	﹤0.01%	161
2024 Q4	$29.1K	Hold	94,264	–	–	﹤0.01%	212
2024 Q3	$30.8K	Hold	94,264	–	–	﹤0.01%	236
2024 Q2	$43.4K	Hold	94,264	–	–	﹤0.01%	248
2024 Q1	$149K	Hold	94,264	–	–	﹤0.01%	205
2023 Q4	$192K	Hold	94,264	–	–	﹤0.01%	272
2023 Q3	$132K	Sell	94,264 -76,114	-45%	-$78.8K	﹤0.01%	315
2023 Q2	$93.7K	Sell	170,378 -4,135	-2%	-$2.19K	﹤0.01%	372
2023 Q1	$118K	Hold	174,513	–	–	﹤0.01%	459
2022 Q4	$288K	Sell	174,513 -173,546	-50%	-$487K	﹤0.01%	562
2022 Q3	$1.61M	Sell	348,059 -19,233	-5%	-$113K	0.02%	650
2022 Q2	$1.86M	Sell	367,292 -32,708	-8%	-$238K	0.02%	664
2022 Q1	$2.85M	Hold	400,000	–	–	0.04%	532
2021 Q4	$3.73M	Buy	400,000 +304,315	+318%	+$2.71M	0.06%	431
2021 Q3	$949K	Hold	95,685	–	–	0.02%	443
2021 Q2	$951K	Buy	+95,685	New	+$963K	0.03%	369
2021 Q1	–	Sell	-17,318	Closed	-$187K	–	458
2020 Q4	$187K	Sell	17,318 -80,443	-82%	-$828K	0.01%	159
2020 Q3	$1.01M	Buy	+97,761	New	+$1.02M	0.04%	101

Other funds holding STLN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

KWM

Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Saba Capital Management's STLN Position: Q3 2025 in Review

Saba Capital Management sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q3 2025, closing a stake of 94,264 shares — an estimated $193K sold.

Saba Capital Management first reported a position in STLN in Q3 2020 and held it in 19 quarters. The position peaked at $3.73M in Q4 2021. 108 funds tracked by Wall St. Rank hold STLN as of Q3 2025.

Saba Capital Management reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Saba Capital Management sold 94,264 Starling Oncology Institute, Inc. Common Stock shares in Q3 2025, an estimated $193K.
Saba Capital Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2020 and held it in 19 quarters.
Saba Capital Management's Starling Oncology Institute, Inc. Common Stock position peaked at $3.73M in Q4 2021.
108 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q3 2025.

Based on Saba Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.